New Search

Your search found 5 records, sorted by year and then date of acquisition.

1. Impact of Research Network Participation on the Adoption of Buprenorphine for Substance Abuse Treatment. doc type
  Rieckmann, Traci R. ; Abraham, Amanda J. ; Kovas, Anne E. ; McFarland, Bentson H. ; Roman, Paul M.
 Addictive Behaviors 2014;39(5):889-896. [doi: 10.1016/j.addbeh.2014.01.016].
 
2. A Multi-Level Analysis of Counselor Attitudes Toward the Use of Buprenorphine in Substance Abuse Treatment. doc type
  Rieckmann, Traci R. ; Kovas, Anne E. ; McFarland, Bentson H. ; Abraham, Amanda J.
 Journal of Substance Abuse Treatment 2011;41(4):374-385. [doi: 10.1016/j.jsat.2011.05.005].
 
3. Using a Standardized Patient Walk-Through to Improve Implementation of Clinical Trials. doc type
  Fussell, Holly E. ; Kunkel, Lynn E. ; Lewy, Colleen S. ; McFarland, Bentson H. ; McCarty, Dennis
 Journal of Substance Abuse Treatment 2008;35(4):470-475. [doi: 10.1016/j.jsat.2008.03.001].
 
4. Using Standardized Patients to Pilot Screening Visits in Clinical Trials. doc type
  Kunkel, Lynn E. ; Fussell, Holly E. ; Shannon-Lewy, Colleen ; McFarland, Bentson H.
 Poster presented at the Society for Clinical Trials Annual Meeting, Montreal, Canada, May 20-23, 2007.
 
5. Standardized Patients as Participants in Clinical Trials Protocol Implementation. doc type
  Fussell, Holly E. ; Kunkel, Lynn E. ; Shannon-Lewy, Colleen ; McFarland, Bentson H.
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science & Practice: Bridges to the Future," Seattle, WA, October 16-17, 2006.
 

New Search